MyndBlue's development strategy is based on two essential pillars: innovative technology and rigorous clinical studies. Today, MyndBlue has the capability to capture real-time, ultra-precise biometric data: MyndBlue has patented technology embedded in a discreet bracelet that captures the warning signs of a patient’s disease-status changes and alerts the doctor; MyndBlue is 250 times more sensitive than popular health- and fitness-trackers on the market today. MyndBlue is in the midst of various clinical studies involving elite institutions to enrich its scientific database and to identify symptoms that have never before been correlated with the diseases of MDD and PTSD. Clinical trials are allowing MyndBlue to further enhance its sophisticated algorithm, refine the diseases criteria continuously, and facilitate a level of mental-healthcare never before reached.